Halaven Injection
Product Images NDC 43624-002

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Halaven (NDC 43624-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bsp Pharmaceuticals Spa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (eribulin Mesylate) Injection1 mg/2 mL(0.5 mg/ml)for Intravenous Use (Eisai Halaven Label)

Label for Halaven (eribulin mesylate) injection, 0.5 mg/mL, 2 mL vial. The label includes manufacturer information from Eisai Manufacturing Limited, storage instructions (15°-25°C, do not freeze), barcodes, and identifies BSP Pharmaceuticals SpA in Italy as the manufacturer. The label highlights the intravenous route and provides product NDC 43624-002-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.